![Kenneth P. H. Pritzker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth P. H. Pritzker
Gründer bei Rna Diagnostics, Inc.
Aktive Positionen von Kenneth P. H. Pritzker
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Rna Diagnostics, Inc.
![]() Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 01.01.2010 | - |
Gründer | 01.01.2010 | - |
Karriereverlauf von Kenneth P. H. Pritzker
Ehemalige bekannte Positionen von Kenneth P. H. Pritzker
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CARERX CORPORATION | Direktor/Vorstandsmitglied | 25.06.2009 | 25.06.2009 |
Statistik
International
Kanada | 3 |
Operativ
Director/Board Member | 2 |
Founder | 1 |
Sektoral
Health Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CARERX CORPORATION | Health Services |
Private Unternehmen | 1 |
---|---|
Rna Diagnostics, Inc.
![]() Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- Kenneth P. H. Pritzker
- Erfahrung